While Passage Bio Inc has overperformed by 0.86%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PASG fell by -29.31%, with highs and lows ranging from $1.33 to $0.26, whereas the simple moving average fell by -22.93% in the last 200 days.
On November 29, 2024, Wedbush started tracking Passage Bio Inc (NASDAQ: PASG) recommending Outperform. A report published by Rodman & Renshaw on September 03, 2024, Initiated its previous ‘Buy’ rating for PASG. Goldman January 19, 2022d the rating to Neutral on January 19, 2022, and set its price target from $29 to $6. Raymond James initiated its ‘Outperform’ rating for PASG, as published in its report on July 01, 2021. BTIG Research’s report from June 15, 2021 suggests a price prediction of $25 for PASG shares, giving the stock a ‘Buy’ rating. Goldman also rated the stock as ‘Buy’.
Analysis of Passage Bio Inc (PASG)
In order to gain a clear picture of Passage Bio Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -83.73% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.74, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 319.50K can be a very valuable indicator of volatility for PASG stock. On a monthly basis, the volatility of the stock is set at 11.41%, whereas on a weekly basis, it is put at 13.43%, with a loss of -13.07% over the past seven days. Furthermore, long-term investors anticipate a median target price of $6.00, showing growth from the present price of $0.4, which can serve as yet another indication of whether PASG is worth investing in or should be passed over.
How Do You Analyze Passage Bio Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 14.38%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 43.12% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PASG shares are owned by institutional investors to the tune of 43.12% at present.
